Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 240 results for "biocon"

Biocon acquires Acacia unit

Pharma giant Biocon has acquired business assets of Acacia Life Sciences Private Limited, which has a unit at Jawaharlal Nehru Pharma City (JNPC) at Parawada.Acacia Life Sciences manufacture... The Hindu, 11 hours ago

168 images for biocon

DNA India, 1 day ago, 1 week ago, 1 week ago
Ani News, 1 week ago
DNA India, 3 weeks ago
NDTV Profit, 3 weeks ago
India Infoline, 1 month ago
India Infoline, 1 month ago
DNA, 1 month ago
Financial Express, 1 month ago
DNA India

Biocon acquires Vizag-based company’s manufacturing plant

Biotechnology major Biocon said on Thursday that it has acquired a manufacturing unit of Vishakapatnam-based Acacia Lifesciences for an undisclosed amount.The company has acquired busine...
 Business Line1 day ago Biocon’s new buy may boost sentiment  Business Line1 day ago Biocon acquires Vishakhapatnam-based Acacia Lifesciences  DNA India2 days ago

No easy way out for Biocon

Bengaluru: Kiran Mazumdar-Shaw, 62, chairperson and managing director of Biocon Ltd, is a self-made woman. Having grown Biocon from a small industrial-enzymes producer into India's largest biotechnology company, earning Rs. 2,200 crore in revenue, ...
 Livemint.com1 week ago Mazumdar-Shaw slams Cong for parliament logjam  Business Standard1 month ago Biocon chairman Kiran Mazumdar-Shaw slams Congress for parliament logjam  DNA1 month ago Kiran Mazumdar-Shaw slams Congress for parliament logjam  DeshGujarat1 month ago
Siasat Daily

Lobbying by U.S. pharmaceutical companies not in India's interest: Kiran Mazumdar Shaw

The CEO of India's leading pharmaceutical company - BioCon - Ms. Kiran Mazumdar Shaw who, is in Washington to participate in the CEO's Forum of the India - US Strategic and Commercial Dialogue, has warned that excessive lobbying by American pharmaceutical ...
 Business Standard1 week ago Compliance culture should be driven from the top in pharma companies: Kiran Mazumdar Shaw  Business Standard1 month ago

Stocks to watch: LT, Prestige Estates, Tata Motors, IDBI

HDFC | Maruti Suzuki | Larsen and Toubro | Prestige Estates | NBCC | Greenply Industries | Hester Biosciences | Tata Motors | TVS Motor | Escorts | IDBI Bank | Cummins India | Hitachi Home | Navin Fluorine International | Adani Ports and Biocon are stocks, ...
 Money Control1 day ago
Global Information Inc

Global Cephalosporin Drugs Market 2015-2019

About cephalosporins Cephalosporins are bactericidal antibiotics and act by inhibiting cell wall synthesis. They inhibit a wide variety of gram-positive and gram-negative bacteria. They are considered broad-spectrum antibiotics with similar ...
 Global Information Inc5 days ago Global Human Insulin Market 2015-2019  TheStreet.com3 weeks ago Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020  Sys-Con Media1 month ago

Government education grant to help grow Texas bioprocessing industry

Austin Community College has received a Government grant to establish a centre for biotechnology technicians it hopes will provide skilled workers for the Texas biomanufacturing industry. The $2.9m (€2.6m) Undergraduate Education grant from ...
 BioPharma-Reporter.com3 days ago
India Infoline

Biocon slumps by 2%; plans to set up manufacturing facility!

*Password should have 8 to 12 Alphanumeric Characters with one Special Character. Confirm Password I want to create a User ID and have read the terms and conditions for the same Register Now Connect with We encourage visitors to register on IIFL. Registering ...
 India Infoline1 month ago Biocon stock up 1% ; plans to invest $100 mn for new plant in Mangalore SEZ  India Infoline1 month ago Syngene to invest $100 mn for new plant in Mangalore SEZ  Economic Times1 month ago Syngene makes strong debut on the bourses, jumps 24%  Economic Times1 month ago

Biocon opens facility to produce devices for insulin portfolio

Press Trust of India | Bengaluru September 15, 2015 Last Updated at 21:13 IST Biotechnology major Biocon today opened a facility to manufacture devices for its insulin portfolio. Spread over 10,000 square feet, the facility will manufacture pen like delivery ...
 Business Standard2 weeks ago Biocon launches pen like device to administer insulin  Business Standard2 weeks ago Biocon opens new facility to make insulin devices in India  Business Line2 weeks ago Biocon opens new facility for insulin devices  India Infoline2 weeks ago
DNA India

Speed up pace of ease of doing business: Kiran Mazumdar Shaw

Biocon CMD Kiran Mazumdar-Shaw Highlighting the need for the government to quickly remove bottlenecks to improve ease of doing business, Biocon CMD Kiran Mazumdar-Shawon Wednesday said 'impatience is seeping in' which could lead to confidence ...
 DNA India3 weeks ago Rajan bid to soothe nerves  Calcutta Telegraph1 month ago Shaw junks museum adoption proposal, raises pitch on its affairs  Bangalore Mirror1 month ago Major progress in IPR policy, should roll out yr-end:Biocon  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon
Get updated on latest news & your favorite topics right in your inbox!
More     Less